HOME >> MEDICINE >> NEWS
The lancet infectious diseases (TLID) October press release

Bacterial eradication in the treatment of otitis media

Otitis media (middle-ear infection) is a common infectious disease of early childhood; an estimated 20 million cases occur in the USA annually. This review assesses the impact of antibacterial treatment, commenting on how clinicians may become mislead by drug treatment as otitis media often resolves naturally within a few days of infection; the growing problem of widespread antibiotic resistance is also limiting the effectiveness of many therapeutic treatments for the disorder.

Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa?

This review calls for the re-introduction of strategies to target the larvael stage of the anopheles mosquito as part of the global 'Roll Back Malaria' campaign.

OTHER REVIEWS:

Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections

This systematic review and meta-analysis of randomised controlled trials involving more than 5000 women provides further evidence that a cheap and commonly used spermicide gel is not effective in reducing HIV-1 and other sexually transmitted infections.

Staphylococcus aureus disease in drug users
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
4-Oct-2002


Page: 1

Related medicine news :

1. The lancet specialty journals press releases
2. Physicians call for increased funding for federal infectious disease programs
3. Mailman School of Public Health researchers develop infectious disease diagnostic tool
4. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
5. NIAID launches program to improve medical tools against emerging infectious diseases
6. Study suggests better use of web could improve infectious disease reporting
7. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
8. Two centres for infectious diseases established
9. Expert guide to infectious diseases published
10. Stress may increase susceptibility to infectious disease
11. First mouse model for multiple system atrophy points to new treatment targets for brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The lancet infectious diseases TLID October press release

(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:3/28/2015)... Designers and Professionals of FCPX ... 5K from Pixel Film Studios. , “Scratches 5K allows ... inside Final Cut Pro X” Said Christina Austin, CEO ... is an effective tool for any FCPX editor.” , ... intuitive grunge overlays. Simply drag title layers into the ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Wellness for ... and business criteria for the spa and wellness industry–has ... clients who have experienced or are living with cancer. ... Spafinder Wellness 365® Network, will be identified with a ... as a provider of safe, therapeutic services for cancer ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 The ... ) that allege the statin medication increases the risk ... granted Pfizer Inc.’s Motion to Dismiss four individual cases ... a Case Management Order issued in the U.S. District ... Court determined that the dismissals were warranted because the ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
Cached News: